Anyue L. Yin
Leiden, ZH 2333ZA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Model-Informed Dose Optimization of Pazopanib in Real-World Patients with Cancer.
Journal: Clinical pharmacokinetics
Published: March 24, 2025
Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System Lymphoma.
Journal: Clinical pharmacokinetics
Published: October 28, 2024
Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens.
Journal: Clinical pharmacokinetics
Published: April 18, 2024
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 10, 2023
Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance.
Journal: Scientific reports
Published: March 23, 2022
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing.
Journal: Clinical pharmacokinetics
Published: July 02, 2020
A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 01, 2019
Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstriction.
Journal: British journal of pharmacology
Published: May 18, 2018
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.
Journal: Bone marrow transplantation
Published: May 10, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026